Indogulf Cropsciences Q1 FY27 Results: Revenue down 11% YoY, PAT falls 38%

Revenue DeclineExceptional ItemResults View source PDF Explain this filing

IGCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹72.50

prior close

₹72.01

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.4% vs market

Pesticides & Agrochemicals peers, median of 28sector-1.1%+1.1% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 1.1 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.7

10m

-1.1

15m

-2.8

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.4-0.4-1.1+1.1

Next day

-2.1+0.5-2.6-1.5-0.6

-2.2+0.6-2.8-2.3+0.1

-2.1+0.7-2.8-2.3+0.3

-1.1+1.1-2.2-3.2+2.1

-0.3+0.5-0.8-3.3+3.0

+0.6+1.3-0.7-2.8+3.4

15d

+0.8+0.5+0.2-4.0+4.7

-8.1-0.8-7.3-6.3-1.8

-22.6-0.9-21.7-11.3-11.3

—————

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indogulf Cropsciences reported Q1 FY27 (quarter ended June 30, 2026) consolidated revenue of Rs 1,685.45 million, down about 11% from Rs 1,893.72 million in Q1 FY26. PAT fell to Rs 24.14 million from Rs 38.67 million (around 38% YoY decline). EPS stood at Rs 0.38 vs Rs 0.80. Standalone revenue declined to Rs 1,623.96 million from Rs 1,851.38 million. Auditor Devesh Parekh and Co gave an un-modified limited review opinion. Company operates in agro-chemicals (Technical and Formulation) segment.

Likely market impact

Weak quarter with double-digit decline in both revenue and profit. May weigh on stock sentiment in the near term.